Skip to main content
Journal cover image

Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom.

Publication ,  Journal Article
Allocca, CM; Bledsoe, MJ; Albert, M; Anisimov, SV; Bravo, E; Castelhano, MG; Cohen, Y; De Wilde, M; Furuta, K; Kozlakidis, Z; Martin, D ...
Published in: Biopreserv Biobank
December 2020

The era of COVID-19 has brought about a number of novel challenges for the global biobanking community. To better position the biobanking community to cope with current and future challenges, the International Society for Biological and Environmental Repositories (ISBER) COVID-19 Response Task Force was convened to identify needs and gaps in biobanking tools (existing resources that support good practice), for example, standards, best practices, business, etc. and to make recommendations to benefit the community. Toward these goals, the Task Force assembled a set of questions to explore individual biobanks' experiences, with emphasis on identification of key challenges and approaches, including tools employed. A survey was designed with the use of these questions and administered by ISBER. This article presents a summary of the aggregated data obtained from the survey responses, illustrating some of the major issues encountered and identifying which tools the survey respondents found most useful. In particular, this article focuses on the challenges identified during the early months of the COVID-19 era. Recommendations are provided to support biobank emergency preparedness for the future, address lessons learned, and propose solutions to bridge identified gaps. The analysis and the complete survey dataset will also inform the larger Task Force goal to develop specific tool recommendations.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Biopreserv Biobank

DOI

EISSN

1947-5543

Publication Date

December 2020

Volume

18

Issue

6

Start / End Page

533 / 546

Location

United States

Related Subject Headings

  • SARS-CoV-2
  • Pandemics
  • Humans
  • COVID-19
  • Biological Specimen Banks
  • 3102 Bioinformatics and computational biology
  • 1004 Medical Biotechnology
  • 0601 Biochemistry and Cell Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Allocca, C. M., Bledsoe, M. J., Albert, M., Anisimov, S. V., Bravo, E., Castelhano, M. G., … Snapes, E. (2020). Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom. Biopreserv Biobank, 18(6), 533–546. https://doi.org/10.1089/bio.2020.0082
Allocca, Clare M., Marianna J. Bledsoe, Monique Albert, Sergey V. Anisimov, Elena Bravo, Marta G. Castelhano, Yehudit Cohen, et al. “Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom.Biopreserv Biobank 18, no. 6 (December 2020): 533–46. https://doi.org/10.1089/bio.2020.0082.
Allocca CM, Bledsoe MJ, Albert M, Anisimov SV, Bravo E, Castelhano MG, et al. Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom. Biopreserv Biobank. 2020 Dec;18(6):533–46.
Allocca, Clare M., et al. “Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom.Biopreserv Biobank, vol. 18, no. 6, Dec. 2020, pp. 533–46. Pubmed, doi:10.1089/bio.2020.0082.
Allocca CM, Bledsoe MJ, Albert M, Anisimov SV, Bravo E, Castelhano MG, Cohen Y, De Wilde M, Furuta K, Kozlakidis Z, Martin D, Martins A, McCall S, Morrin H, Pugh RS, Schacter B, Simeon-Dubach D, Snapes E. Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom. Biopreserv Biobank. 2020 Dec;18(6):533–546.
Journal cover image

Published In

Biopreserv Biobank

DOI

EISSN

1947-5543

Publication Date

December 2020

Volume

18

Issue

6

Start / End Page

533 / 546

Location

United States

Related Subject Headings

  • SARS-CoV-2
  • Pandemics
  • Humans
  • COVID-19
  • Biological Specimen Banks
  • 3102 Bioinformatics and computational biology
  • 1004 Medical Biotechnology
  • 0601 Biochemistry and Cell Biology